# A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets

> **NCT03684265** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Meloxicam Capsule (Test)
- **DRUG:** Meloxicam Tablet (Reference)

## Key facts

- **NCT ID:** NCT03684265
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-05
- **Primary completion:** 2018-10-30
- **Final completion:** 2018-11-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03684265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03684265, "A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03684265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*